• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病冠状动脉可视化的预测因素。

Predictors of coronary artery visualization in Kawasaki disease.

机构信息

Children's Hospital Boston and Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Am Soc Echocardiogr. 2011 Jan;24(1):53-9. doi: 10.1016/j.echo.2010.10.015.

DOI:10.1016/j.echo.2010.10.015
PMID:21172596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3022385/
Abstract

BACKGROUND

Echocardiography is the imaging modality of choice for the evaluation of coronary artery (CA) abnormalities in Kawasaki disease. Small series have established high specificity and sensitivity for detecting abnormalities, yet visualization rates of individual CA segments and factors associated with success are unknown.

METHODS

In the Pediatric Heart Network's randomized trial of primary steroid treatment for Kawasaki disease, echocardiograms were interpreted locally and by a core laboratory. Univariate and multivariate predictors of CA visualization by the local lab as determined by the core lab were explored, and agreement of CA size measured locally and by the core lab was assessed.

RESULTS

A total of 589 echocardiograms from 199 patients were obtained over 27 months. Visualization rates for the left main, proximal and distal left anterior descending, and proximal right CAs ranged from 91% to 98% but were lower for the distal right (65%), circumflex (86%), and posterior descending (54%) CAs. For the distal right and circumflex CAs, visualization rates improved over the course of the study (P<.05). In multivariate analysis, local center, CA segment, and time from study start to echocardiography were independent predictors of visualization (all P values<.001). For segments for which visualization rates varied by center, higher percentage visualization was associated with larger center volume (P=.001). Routine sedation use was also associated with higher visualization rates.

CONCLUSIONS

Successful CA visualization in Kawasaki disease is associated with the segment being evaluated and is influenced by center volume and sedation use. Increased visualization rates over time suggest a learning curve and underscore the value of core lab oversight in pediatric multicenter trials.

摘要

背景

超声心动图是评估川崎病冠状动脉(CA)异常的首选影像学检查方法。一些小系列研究已经证实了其在检测异常方面具有很高的特异性和敏感性,但对于单个 CA 节段的可视化率以及与成功相关的因素尚不清楚。

方法

在儿科心脏网络的川崎病一线类固醇治疗的随机试验中,超声心动图由当地实验室和核心实验室进行解读。通过核心实验室确定了当地实验室确定的 CA 可视化的单变量和多变量预测因素,并评估了当地和核心实验室测量的 CA 大小的一致性。

结果

在 27 个月的时间里,从 199 名患者中总共获得了 589 份超声心动图。左主干、近端和远端左前降支以及近端右冠状动脉的可视化率从 91%到 98%不等,但远端右(65%)、回旋支(86%)和后降支(54%)的可视化率较低。对于远端右和回旋支 CA,可视化率在研究过程中有所提高(P<.05)。多变量分析显示,当地中心、CA 节段以及从研究开始到超声心动图的时间是可视化的独立预测因素(所有 P 值<.001)。对于可视化率因中心而异的节段,较高的百分比可视化与更大的中心体积相关(P=.001)。常规镇静的使用也与更高的可视化率相关。

结论

川崎病中成功的 CA 可视化与正在评估的节段有关,并且受到中心体积和镇静使用的影响。随着时间的推移,可视化率的增加表明存在学习曲线,并强调了核心实验室监督在儿科多中心试验中的价值。

相似文献

1
Predictors of coronary artery visualization in Kawasaki disease.川崎病冠状动脉可视化的预测因素。
J Am Soc Echocardiogr. 2011 Jan;24(1):53-9. doi: 10.1016/j.echo.2010.10.015.
2
Marked variations in serial coronary artery diameter measures in Kawasaki disease: a new indicator of coronary involvement.川崎病冠状动脉直径的系列测量值有明显变化:冠状动脉受累的一个新指标。
J Am Soc Echocardiogr. 2012 Aug;25(8):859-65. doi: 10.1016/j.echo.2012.05.019.
3
Usefulness of real-time 3-dimensional echocardiography for the evaluation of coronary artery morphology in patients with Kawasaki disease.实时三维超声心动图在川崎病患者冠状动脉形态评估中的应用价值
J Am Soc Echocardiogr. 2007 Aug;20(8):930-3. doi: 10.1016/j.echo.2007.01.024. Epub 2007 Jun 6.
4
Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms.川崎病合并动脉瘤患者超声心动图与心脏 CT 冠状动脉测量的比较。
J Cardiovasc Comput Tomogr. 2022 Jan-Feb;16(1):43-50. doi: 10.1016/j.jcct.2021.09.002. Epub 2021 Sep 16.
5
Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.川崎病患者初始冠状动脉正常与随访超声心动图正常的相关性。
JAMA Pediatr. 2018 Dec 1;172(12):e183310. doi: 10.1001/jamapediatrics.2018.3310. Epub 2018 Dec 3.
6
Limitations of echocardiographic periarterial brightness in the diagnosis of Kawasaki disease.超声心动图动脉周围亮度在川崎病诊断中的局限性。
J Am Soc Echocardiogr. 2005 Jul;18(7):768-70. doi: 10.1016/j.echo.2004.12.017.
7
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.美国和日本川崎病患儿的冠状动脉结局
Int J Cardiol. 2013 Oct 9;168(4):3825-8. doi: 10.1016/j.ijcard.2013.06.027. Epub 2013 Jul 11.
8
Distal coronary artery abnormalities in Kawasaki disease: experience on CT coronary angiography in 176 children.川崎病的冠状动脉远端异常:176 例儿童的 CT 冠状动脉造影经验
Rheumatology (Oxford). 2023 Feb 1;62(2):815-823. doi: 10.1093/rheumatology/keac217.
9
Coronary artery dimensions in febrile children without Kawasaki disease.发热患儿中无川崎病的冠状动脉尺寸。
Circ Cardiovasc Imaging. 2013 Mar 1;6(2):239-44. doi: 10.1161/CIRCIMAGING.112.000159. Epub 2013 Jan 28.
10
Predictors of inadequate initial echocardiography in suspected Kawasaki disease: Criteria for sedation.疑似川崎病初始超声心动图检查不充分的预测因素:镇静标准。
Congenit Heart Dis. 2018 May;13(3):470-475. doi: 10.1111/chd.12598. Epub 2018 Mar 9.

引用本文的文献

1
Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki Disease.儿童多系统炎症综合征与川崎病冠状动脉受累情况对比
J Am Heart Assoc. 2025 May 6;14(9):e037761. doi: 10.1161/JAHA.124.037761. Epub 2025 Apr 23.
2
The value of CT coronary angiography for a comprehensive assessment of left circumflex artery in Kawasaki disease: 9 years of experience from a tertiary center.CT冠状动脉造影在川崎病左旋支动脉综合评估中的价值:来自三级中心的9年经验
Lancet Reg Health Southeast Asia. 2024 Aug 23;29:100471. doi: 10.1016/j.lansea.2024.100471. eCollection 2024 Oct.
3
Late onset Kawasaki disease with multiple coronary arterial aneurysms: A case report.迟发性川崎病合并多发冠状动脉瘤:一例报告
Radiol Case Rep. 2024 Aug 10;19(11):4762-4765. doi: 10.1016/j.radcr.2024.07.066. eCollection 2024 Nov.
4
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry.COVID-19 与 MIS-C 时期的川崎病:国际川崎病注册研究。
Can J Cardiol. 2024 Jan;40(1):58-72. doi: 10.1016/j.cjca.2023.06.001. Epub 2023 Jun 7.
5
Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.川崎病后冠状动脉瘤的中期并发症:来自国际川崎病注册研究。
J Am Heart Assoc. 2020 Aug 4;9(15):e016440. doi: 10.1161/JAHA.119.016440. Epub 2020 Jul 28.
6
Intravenous Immunoglobulin Infusion Reactions in Kawasaki Disease Patients Who Undergo Sedation.接受镇静的川崎病患者静脉注射免疫球蛋白的反应
J Pediatr Pharmacol Ther. 2020;25(3):251-255. doi: 10.5863/1551-6776-25.3.251.
7
Diagnosis of Kawasaki disease.川崎病的诊断
Int J Rheum Dis. 2018 Jan;21(1):36-44. doi: 10.1111/1756-185X.13224. Epub 2017 Nov 13.
8
Unplanned Repeat Echocardiography with Sedation in Children: Patient Risk Factors.儿童镇静下的非计划重复超声心动图检查:患者风险因素
Pediatr Cardiol. 2016 Aug;37(6):1057-63. doi: 10.1007/s00246-016-1391-x. Epub 2016 Apr 18.
9
Ascending Aorta Elastography After Kawasaki Disease Compared to Systemic Hypertension.川崎病后升主动脉弹性成像与系统性高血压的比较
Pediatr Cardiol. 2015 Oct;36(7):1417-22. doi: 10.1007/s00246-015-1175-8. Epub 2015 Apr 29.
10
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan.美国和日本川崎病患儿的冠状动脉结局
Int J Cardiol. 2013 Oct 9;168(4):3825-8. doi: 10.1016/j.ijcard.2013.06.027. Epub 2013 Jul 11.

本文引用的文献

1
Hype and hope in the use of echocardiography for selection for cardiac resynchronization therapy: the Tower of Babel revisited.超声心动图用于心脏再同步治疗选择中的炒作与希望:重温巴别塔之乱。
Circulation. 2008 May 20;117(20):2573-6. doi: 10.1161/CIRCULATIONAHA.108.772475.
2
Results of the Predictors of Response to CRT (PROSPECT) trial.心脏再同步化治疗反应预测因子(PROSPECT)试验的结果。
Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.
3
Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.川崎病患儿的冠状动脉受累情况:基于系列标准化测量分析的危险因素
Circulation. 2007 Jul 10;116(2):174-9. doi: 10.1161/CIRCULATIONAHA.107.690875. Epub 2007 Jun 18.
4
How to image Kawasaki disease: a validation of different imaging techniques.如何对川崎病进行成像:不同成像技术的验证
Int J Cardiol. 2008 Feb 20;124(1):27-31. doi: 10.1016/j.ijcard.2007.02.035. Epub 2007 Apr 16.
5
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.脉冲式皮质类固醇疗法用于川崎病初始治疗的随机试验。
N Engl J Med. 2007 Feb 15;356(7):663-75. doi: 10.1056/NEJMoa061235.
6
Chloral hydrate sedation for pediatric echocardiography: physiologic responses, adverse events, and risk factors.用于儿科超声心动图检查的水合氯醛镇静:生理反应、不良事件及危险因素。
Pediatrics. 2006 Mar;117(3):e434-41. doi: 10.1542/peds.2005-1445. Epub 2006 Feb 15.
7
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.川崎病的诊断、治疗及长期管理:美国心脏协会青少年心血管疾病理事会风湿热、心内膜炎及川崎病委员会给卫生专业人员的声明
Circulation. 2004 Oct 26;110(17):2747-71. doi: 10.1161/01.CIR.0000145143.19711.78.
8
Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction.在一项针对急性心肌梗死患者的为期两年的随访研究中,当地研究人员与核心实验室在左心室尺寸及功能的超声心动图测量方面的差异。
Eur J Echocardiogr. 2002 Dec;3(4):263-70.
9
Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in heart failure trial (Val-HeFT).一项大型多中心国际研究中心脏超声心动图检查表现的质量评估与质量控制:缬沙坦治疗心力衰竭试验(Val-HeFT)
J Am Soc Echocardiogr. 2002 Apr;15(4):293-301. doi: 10.1067/mje.2001.115103.
10
Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study.多中心小儿左心室结构与功能超声心动图测量的可靠性:前瞻性P(2)C(2) HIV研究
Circulation. 2001 Jul 17;104(3):310-6. doi: 10.1161/01.cir.104.3.310.